Cost-effectiveness analysis of new-generation drug-eluting stents for myocardial infarction: a nationwide population-based study

Background Drug-eluting stents (DESs) are the preferred treatment for myocardial infarction (MI) but are not reimbursed under some national health insurance (NHI) systems. Therefore, those who care about long-term effectiveness might face economic limitations when selecting DESs. Moreover, limited information is available concerning the cost-effectiveness analysis of new-generation (including second- and third-generation) DESs. We used nationwide population-based data to evaluate the cost-effectiveness of new-generation DESs compared to bare-metal stents (BMSs) from the NHI perspective. Methods We included all 10,672 MI patients who underwent stent implantation in 2018 in Taiwan and were followed to 2023 through Taiwan’s NHI database. After 1:1 propensity score matching, 3,913 patients were in each BMS and DES group. Multivariable Cox and linear regression models were performed to evaluate the effect of DES use on 1-, 2-, and 5-year mortality and medical cost, respectively. Then, the incremental cost-effectiveness ratios (ICERs) were calculated. Results Patients receiving DESs had 52%, 48%, and 43% lower risks of 1-, 2-, and 5-year mortality and NT$27,839 higher 1-year costs compared to those receiving BMSs, respectively. The 1-, 2-, and 5-year ICERs for DESs were NT$463,983, NT$241,299, and NT$302,750 per death avoided, respectively. Conclusions New-generation DESs are cost-effective based on the cost-effectiveness threshold recommended by the World Health Organization. Considering the effectiveness and cost of new-generation DESs, including reimbursement for this technology under the NHI system would benefit beneficiaries and enhance long-term survival for MI.

Authors

Institutions

Publication Details

Journal
International Journal for Quality in Health Care
Published
2026-11-19
DOI
https://doi.org/10.1093/intqhc/mzag193
Primary Topic
Coronary Interventions and Diagnostics
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Cost-effectiveness analysis of new-generation drug-eluting stents for myocardial infarction: a nationwide population-based study

Yu‐Chi Tung, Guann-Ming Chang
International Journal for Quality in Health Care
Coronary Interventions and Diagnostics
article

Cost-effectiveness analysis of new-generation drug-eluting stents for myocardial infarction: a nationwide population-based study

Yu‐Chi Tung, Guann-Ming Chang
article en

Abstract

Background Drug-eluting stents (DESs) are the preferred treatment for myocardial infarction (MI) but are not reimbursed under some national health insurance (NHI) systems. Therefore, those who care about long-term effectiveness might face economic limitations when selecting DESs. Moreover, limited information is available concerning the cost-effectiveness analysis of new-generation (including second- and third-generation) DESs. We used nationwide population-based data to evaluate the cost-effectiveness of new-generation DESs compared to bare-metal stents (BMSs) from the NHI perspective. Methods We included all 10,672 MI patients who underwent stent implantation in 2018 in Taiwan and were followed to 2023 through Taiwan’s NHI database. After 1:1 propensity score matching, 3,913 patients were in each BMS and DES group. Multivariable Cox and linear regression models were performed to evaluate the effect of DES use on 1-, 2-, and 5-year mortality and medical cost, respectively. Then, the incremental cost-effectiveness ratios (ICERs) were calculated. Results Patients receiving DESs had 52%, 48%, and 43% lower risks of 1-, 2-, and 5-year mortality and NT$27,839 higher 1-year costs compared to those receiving BMSs, respectively. The 1-, 2-, and 5-year ICERs for DESs were NT$463,983, NT$241,299, and NT$302,750 per death avoided, respectively. Conclusions New-generation DESs are cost-effective based on the cost-effectiveness threshold recommended by the World Health Organization. Considering the effectiveness and cost of new-generation DESs, including reimbursement for this technology under the NHI system would benefit beneficiaries and enhance long-term survival for MI.

International Journal for Quality in Health Care
National Taiwan University (TW), Chang Gung Memorial Hospital (TW), Linkou Chang Gung Memorial Hospital (TW)
Coronary Interventions and Diagnostics
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon